From the blog a couple stories on the latest DEA efforts to work with e-prescribing..states basically that they are in support of the process, but want to ensure the proper tracking is in place... according to the latest congressional testimony...and I guess we can stay tuned.
Physicians will be able to date a prescription for a fill date in the
future on some controlled drugs..."Do not fill until______", which will
be a big help in not forcing patients to return for an additional
office visit when it is not warranted with the medical condition. BD
Although
not in effect until 30 days from the date of the final ruling on
"Issuance of Multiple Prescriptions for Schedule II Controlled
Substances," this rule change allows physicians to write three separate
prescriptions with staggered fill dates. Patients can still be given
the equivalent of a 90-day prescription for schedule II controlled
substances when medically appropriate. Schedule II drugs are those that
have recognized medical uses as well as a potential for dependence and
abuse. Consequently, these drugs are carefully controlled and regulated
by the DEA. The DEA now allows physicians to use their professional
judgment to carefully control the amount of a controlled substance
issued to a patient at one time.
Statement from the DEA regarding Electronic Prescribing before the Senate Judiciary Committee...BD
DEA
is keenly aware that pharmaceutical controlled substances are vital
tools for the medical community. DEA also is aware that various public
and private entities are striving to leverage modern-day technology to
streamline its business practices. DEA supports the responsible
adoption of electronic prescriptions for controlled substances in a
manner that will meet statutory obligations and minimize the risk of
diversion. However, in the absence of appropriate controls, allowing
electronic prescriptions for controlled substances would certainly
exacerbate a growing epidemic of prescription drug abuse in the United
States. It is essential that the rules governing the electronic
prescribing of controlled substances do not undermine the ability of
federal, state, and local law enforcement to identify and prosecute
those who engage in diversion and put our citizens at risk.
It
is critical that the technology and standards to be employed include
adequate security that incorporates authentication, nonrepudiation, and
integrity in the record keeping process. These three security-related
elements are necessary to ensure that DEA can fulfill its obligations
under the Controlled Substances Act (CSA).
DEA supports the use of technology to reduce medical errors, streamline the medical process and increase efficiency.
Barbara Duck
Ducknet Services
TabletKiosk Sales Information
Blog: http://ducknetweb.blogspot.com/
The Widget Blog Site: http://ducknet.net/default.aspx
Skype Address: Ducknetservices
Phone: 714-898-1917
Email: barbaraduck@ducknet.net
The palest ink is better than the best memory. - Chinese Proverb